{"transactions":[{"id":686993,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-08-14T20:17:11.000Z","date":"2026-08-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":3761,"price":4.42,"value":16623.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units (\"RSUs\"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations."}],"balance_after":54750,"source":{"system":"sec-edgar","filing":"0001104659-26-097195","document":"tm2623285-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926097195/tm2623285-4_4seq1.xml","form_type":"4"}},{"id":702046,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-28T21:39:22.000Z","date":"2026-07-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":239354,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, these stock options were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying (i) the excess of (A) the Merger Consideration minus (B) the exercise price payable in respect of each share of Common Stock subject to such stock option, by (ii) the number of shares of Common Stock the reporting person would have been entitled to receive upon exercise if such stock option award had vested in full (less applicable tax withholdings). Company stock options with an exercise price per share that exceeds the Merger Consideration were canceled for no consideration, which cancelations are exempt from Section 16 of the Securities Exchange Act of 1934, as amended, pursuant to Rules 16a-4(d) and 16b-6(d) thereunder."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options were originally scheduled to vest 30% on March 13, 2027, 30% on March 13, 2028 and 40% on March 13, 2029."}],"balance_after":0,"derivative":{"exercise_price":13.69,"expiration_date":"2036-03-13","underlying":"Common Stock","underlying_shares":239354},"source":{"system":"sec-edgar","filing":"0001606498-26-000110","document":"wk-form4_1785274760.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000110/wk-form4_1785274760.xml","form_type":"4"}},{"id":702045,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-28T21:39:22.000Z","date":"2026-07-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":444730,"price":25,"value":11118250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the deemed acquisition and disposition of Common Stock pursuant to restricted stock units that were subject to performance-based vesting conditions (each, a Company PRSU), which were previously granted to the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Merger Agreement, these Company PRSUs were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying (i) the Merger Consideration per share of Common Stock by (ii) the number of shares of Common Stock such holder would have been entitled to receive if such Company PRSU award had vested based on (A) actual performance against performance metrics for any one-year performance period completed prior to the Effective Time, (B) for any one-year performance period that is in progress as of the Effective Time, the greater of (1) actual achievement against performance metrics and (2) its target level (although, as referenced below, such awards will be converted at target level with a potential true-up), and (C) deemed achievement at target level for any one-year performance period that has not yet commenced as of the Effective Time (less applicable tax withholdings)."},{"field":"shares","element":"transactionShares","label":"F5","text":"The amount reported represents the aggregate number of Company PRSUs paid out to the Reporting Person at (or within 15 business days following) the Effective Time based on target performance for fiscal year 2026.  In the event that actual performance for fiscal year 2026 exceeds target, the reporting person will receive a true-up payment. The maximum aggregate number of Company PRSUs that the reporting person could earn based on actual performance for fiscal year 2026 is 754,331."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001606498-26-000110","document":"wk-form4_1785274760.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000110/wk-form4_1785274760.xml","form_type":"4"}},{"id":702044,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-28T21:39:22.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":444730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the deemed acquisition and disposition of Common Stock pursuant to restricted stock units that were subject to performance-based vesting conditions (each, a Company PRSU), which were previously granted to the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Merger Agreement, these Company PRSUs were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying (i) the Merger Consideration per share of Common Stock by (ii) the number of shares of Common Stock such holder would have been entitled to receive if such Company PRSU award had vested based on (A) actual performance against performance metrics for any one-year performance period completed prior to the Effective Time, (B) for any one-year performance period that is in progress as of the Effective Time, the greater of (1) actual achievement against performance metrics and (2) its target level (although, as referenced below, such awards will be converted at target level with a potential true-up), and (C) deemed achievement at target level for any one-year performance period that has not yet commenced as of the Effective Time (less applicable tax withholdings)."},{"field":"shares","element":"transactionShares","label":"F5","text":"The amount reported represents the aggregate number of Company PRSUs paid out to the Reporting Person at (or within 15 business days following) the Effective Time based on target performance for fiscal year 2026.  In the event that actual performance for fiscal year 2026 exceeds target, the reporting person will receive a true-up payment. The maximum aggregate number of Company PRSUs that the reporting person could earn based on actual performance for fiscal year 2026 is 754,331."}],"balance_after":444730,"source":{"system":"sec-edgar","filing":"0001606498-26-000110","document":"wk-form4_1785274760.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000110/wk-form4_1785274760.xml","form_type":"4"}},{"id":702043,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-28T21:39:22.000Z","date":"2026-07-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":322194,"price":25,"value":8054850.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of April 13, 2026 (as it has been or may be amended, supplemented, waived or otherwise modified in accordance with its terms, the Merger Agreement), by and among the Issuer, A-AV Holdco I, Inc., a Delaware corporation, and A-AV MergerSub, Inc. (Parent), a Delaware corporation and a wholly-owned subsidiary of Parent, each share of the Issuer's common stock, par value $0.01 per share, that was issued and outstanding immediately prior to the effective time of the Merger (the Effective Time), which occurred on July 27, 2026, was converted into and exchanged for the right to receive $25.00 per share in cash, without interest (the Merger Consideration), payable in accordance with the terms and subject to the conditions of the Merger Agreement."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 270,774 restricted stock units of the Company which were subject to only time-based vesting conditions (each, a Company TRSU). Pursuant to the Merger Agreement, these Company TRSUs were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying (i) the Merger Consideration by (ii) the number of shares of Common Stock the reporting person would have been entitled to receive if such Company TRSUs had vested in full (less applicable tax withholdings)"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001606498-26-000110","document":"wk-form4_1785274760.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000110/wk-form4_1785274760.xml","form_type":"4"}},{"id":726434,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T20:20:34.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":21277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date."}],"balance_after":21277,"derivative":{"exercise_price":4.04,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":21277},"source":{"system":"sec-edgar","filing":"0001104659-26-077778","document":"tm2618965-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926077778/tm2618965-5_4seq1.xml","form_type":"4"}},{"id":726433,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-25T20:20:34.000Z","date":"2026-06-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":3784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of RSUs. No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations."}],"balance_after":58511,"source":{"system":"sec-edgar","filing":"0001104659-26-077778","document":"tm2618965-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926077778/tm2618965-5_4seq1.xml","form_type":"4"}},{"id":726432,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2026-06-25T20:20:34.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":17327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") awarded to the Reporting Person on June 23, 2026 (the \"Grant Date\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date."}],"balance_after":62295,"source":{"system":"sec-edgar","filing":"0001104659-26-077778","document":"tm2618965-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926077778/tm2618965-5_4seq1.xml","form_type":"4"}},{"id":806843,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-16T20:37:39.000Z","date":"2026-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":21194,"price":14.53,"value":307948.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 72,614 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on April 14, 2025 and (ii) vested on April 14, 2026. Each TRSU is the economic equivalent of one share of Common Stock."}],"balance_after":322194,"source":{"system":"sec-edgar","filing":"0001606498-26-000052","document":"wk-form4_1776371856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000052/wk-form4_1776371856.xml","form_type":"4"}},{"id":822524,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-04-01T19:22:02.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":239354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award will vest 30% on March 13, 2027, 30% on March 13, 2028 and 40% on March 13, 2029."}],"balance_after":239354,"derivative":{"exercise_price":13.69,"expiration_date":"2036-03-13","underlying":"Common Stock","underlying_shares":239354},"source":{"system":"sec-edgar","filing":"0001606498-26-000038","document":"wk-form4a_1775071319.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000038/wk-form4a_1775071319.xml","form_type":"4/A","original_submission_date":"2026-04-01"}},{"id":822523,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-01T19:22:02.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":101341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 13, 2027, 1/3 on March 13, 2028 and 1/3 on March 13, 2029. Each TRSU is the economic equivalent of one share of Common Stock."}],"balance_after":343388,"source":{"system":"sec-edgar","filing":"0001606498-26-000038","document":"wk-form4a_1775071319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000038/wk-form4a_1775071319.xml","form_type":"4/A","original_submission_date":"2026-04-01"}},{"id":822522,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-04-01T15:48:16.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":241021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award will vest 30% on March 13, 2027, 30% on March 13, 2028 and 40% on March 13, 2029."}],"balance_after":241021,"derivative":{"exercise_price":13.69,"expiration_date":"2036-03-13","underlying":"Common Stock","underlying_shares":241021},"source":{"system":"sec-edgar","filing":"0001606498-26-000033","document":"wk-form4a_1775058494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000033/wk-form4a_1775058494.xml","form_type":"4/A","original_submission_date":"2026-03-17"}},{"id":822521,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-01T15:48:16.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":101341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 13, 2027, 1/3 on March 13, 2028 and 1/3 on March 13, 2029. Each TRSU is the economic equivalent of one share of Common Stock."}],"balance_after":343388,"source":{"system":"sec-edgar","filing":"0001606498-26-000033","document":"wk-form4a_1775058494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000033/wk-form4a_1775058494.xml","form_type":"4/A","original_submission_date":"2026-03-17"}},{"id":836903,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-17T21:23:12.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":239354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award will vest 30% on March 13, 2027, 30% on March 13, 2028 and 40% on March 13, 2029."}],"balance_after":239354,"derivative":{"exercise_price":13.69,"expiration_date":"2036-03-13","underlying":"Common Stock","underlying_shares":239354},"source":{"system":"sec-edgar","filing":"0001606498-26-000025","document":"wk-form4_1773782588.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000025/wk-form4_1773782588.xml","form_type":"4"}},{"id":836902,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-17T21:23:12.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":101341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 13, 2027, 1/3 on March 13, 2028 and 1/3 on March 13, 2029. Each TRSU is the economic equivalent of one share of Common Stock."}],"balance_after":343388,"source":{"system":"sec-edgar","filing":"0001606498-26-000025","document":"wk-form4_1773782588.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000025/wk-form4_1773782588.xml","form_type":"4"}},{"id":1071425,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-08-08T23:10:18.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") awarded to the Reporting Person on August 7, 2025 (the \"Grant Date\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date."}],"balance_after":44968,"source":{"system":"sec-edgar","filing":"0001104659-25-075780","document":"tm2523004-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925075780/tm2523004-2_4seq1.xml","form_type":"4"}},{"id":1101108,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-26T21:14:15.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":36797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest in one installment on the earlier of (x) the one year anniversary of the Grant Date or (y) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such dates."}],"balance_after":36797,"derivative":{"exercise_price":3.22,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":36797},"source":{"system":"sec-edgar","filing":"0001104659-25-063092","document":"tm2519252-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925063092/tm2519252-1_4seq1.xml","form_type":"4"}},{"id":1101107,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-06-26T21:14:15.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":12422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") awarded to the Reporting Person on June 24, 2025 (the \"Grant Date\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest in one installment on the earlier of (x) the one year anniversary of the Grant Date or (y) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such dates."}],"balance_after":29968,"source":{"system":"sec-edgar","filing":"0001104659-25-063092","document":"tm2519252-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925063092/tm2519252-1_4seq1.xml","form_type":"4"}},{"id":1472162,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:55:00.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":17068,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17068,"derivative":{"exercise_price":7.44,"exercise_date":"2025-06-20","expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":17068},"source":{"system":"sec-edgar","filing":"0001104659-24-074009","document":"tm2417742-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924074009/tm2417742-1_4seq1.xml","form_type":"4"}},{"id":1472161,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-06-21T21:55:00.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":5376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") awarded to the Reporting Person on June 20, 2024. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 20, 2025."}],"balance_after":17546,"source":{"system":"sec-edgar","filing":"0001104659-24-074009","document":"tm2417742-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924074009/tm2417742-1_4seq1.xml","form_type":"4"}},{"id":1558523,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-29T01:00:29.000Z","date":"2024-03-26","kind":"grant","planned":false,"acquired":true,"shares":34633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options shall vest as follows: (1) 7,302 stock options shall vest on the Vesting Date and (2) the remaining 27,331 stock options shall vest in three equal, annual installments beginning on the first anniversary of the Vesting Date, subject to the Reporting Person's continuous service through such date."}],"balance_after":34633,"derivative":{"exercise_price":5,"expiration_date":"2034-03-26","underlying":"Common Stock","underlying_shares":34633},"source":{"system":"sec-edgar","filing":"0001104659-24-040737","document":"tm2410168-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924040737/tm2410168-2_4seq1.xml","form_type":"4"}},{"id":1558522,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-03-29T01:00:29.000Z","date":"2024-03-26","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") awarded to the Reporting Person on March 26, 2024. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (1) 2,000 RSUs vest on June 20, 2024 (the \"Vesting Date\") and (2) the remaining 8,000 RSUs vest in three equal, annual installments beginning on the first anniversary of the Vesting Date, subject to the Reporting Person's continuous service through such dates."}],"balance_after":12170,"source":{"system":"sec-edgar","filing":"0001104659-24-040737","document":"tm2410168-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924040737/tm2410168-2_4seq1.xml","form_type":"4"}},{"id":1927279,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T19:53:48.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."}],"balance_after":0,"derivative":{"exercise_price":3.95,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":19333},"source":{"system":"sec-edgar","filing":"0001251769-23-000020","document":"wf-form4_168065240161265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176923000020/wf-form4_168065240161265.xml","form_type":"4"}},{"id":1927278,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-04-04T19:53:48.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5271,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."}],"balance_after":0,"derivative":{"exercise_price":8.86,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":5271},"source":{"system":"sec-edgar","filing":"0001251769-23-000020","document":"wf-form4_168065240161265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176923000020/wf-form4_168065240161265.xml","form_type":"4"}},{"id":1927277,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-04-04T19:53:48.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":27749,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."}],"balance_after":0,"derivative":{"exercise_price":2.08,"expiration_date":"2030-05-07","underlying":"Common Stock","underlying_shares":27749},"source":{"system":"sec-edgar","filing":"0001251769-23-000020","document":"wf-form4_168065240161265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176923000020/wf-form4_168065240161265.xml","form_type":"4"}},{"id":1927276,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-04-04T19:53:48.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16536,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."}],"balance_after":0,"derivative":{"exercise_price":3.27,"expiration_date":"2029-08-16","underlying":"Common Stock","underlying_shares":16536},"source":{"system":"sec-edgar","filing":"0001251769-23-000020","document":"wf-form4_168065240161265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176923000020/wf-form4_168065240161265.xml","form_type":"4"}},{"id":1927275,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T19:53:48.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15154,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."}],"balance_after":0,"derivative":{"exercise_price":3.98,"expiration_date":"2027-12-12","underlying":"Common Sock","underlying_shares":15154},"source":{"system":"sec-edgar","filing":"0001251769-23-000020","document":"wf-form4_168065240161265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176923000020/wf-form4_168065240161265.xml","form_type":"4"}},{"id":1927274,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T19:53:48.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18112,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the disposition of the reporting person's 3,888 shares of Issuer common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock, was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the disposition of the reporting person's 14,224 shares of Issuer RSUs upon the consummation of the Merger. Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit award granted under any Issuer Stock Plan (each, an \"Issuer RSU\"), whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the Merger Consideration and (2) the aggregate number of shares of Issuer Common Stock underlying such Issuer RSU, less applicable taxes and authorized deductions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of the reporting person's 3,888 shares of Issuer common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock, was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the disposition of the reporting person's 14,224 shares of Issuer RSUs upon the consummation of the Merger. Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit award granted under any Issuer Stock Plan (each, an \"Issuer RSU\"), whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the Merger Consideration and (2) the aggregate number of shares of Issuer Common Stock underlying such Issuer RSU, less applicable taxes and authorized deductions."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001251769-23-000020","document":"wf-form4_168065240161265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176923000020/wf-form4_168065240161265.xml","form_type":"4"}},{"id":2229667,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T21:18:02.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":19333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19333,"derivative":{"exercise_price":3.95,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":19333},"source":{"system":"sec-edgar","filing":"0001251769-22-000054","document":"wf-form4_165542866369886.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176922000054/wf-form4_165542866369886.xml","form_type":"4"}},{"id":2229666,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T21:18:02.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":14224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of Restricted Stock Units (\"RSUs\"). Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the one year anniversary of the grant date."}],"balance_after":18112,"source":{"system":"sec-edgar","filing":"0001251769-22-000054","document":"wf-form4_165542866369886.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176922000054/wf-form4_165542866369886.xml","form_type":"4"}},{"id":2660427,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-21T10:51:47.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":5271,"price":8.86,"value":46701.06,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Fully vested at one year anniversary of grant date."}],"balance_after":64710,"derivative":{"exercise_price":8.86,"exercise_date":"2022-06-17","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":5271},"source":{"system":"sec-edgar","filing":"0001251769-21-000081","document":"wf-form4_162428709483516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000081/wf-form4_162428709483516.xml","form_type":"4"}},{"id":2660426,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T10:51:47.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":3888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Fully vested at one year anniversary of grant date."}],"balance_after":3888,"source":{"system":"sec-edgar","filing":"0001251769-21-000081","document":"wf-form4_162428709483516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000081/wf-form4_162428709483516.xml","form_type":"4"}},{"id":2702719,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":790,"price":6.96,"value":5498.4,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702718,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":600,"price":6.93,"value":4158.0,"ownership":{"direct":true},"balance_after":790,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702717,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":3400,"price":6.92,"value":23528.0,"ownership":{"direct":true},"balance_after":1390,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702716,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":5524,"price":6.91,"value":38170.84,"ownership":{"direct":true},"balance_after":4790,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702715,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":3144,"price":6.9,"value":21693.6,"ownership":{"direct":true},"balance_after":10314,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702714,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":464,"price":6.89,"value":3196.96,"ownership":{"direct":true},"balance_after":13458,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702713,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":1100,"price":6.88,"value":7568.0,"ownership":{"direct":true},"balance_after":13922,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702712,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":20,"price":6.85,"value":137.0,"ownership":{"direct":true},"balance_after":15022,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702711,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":500,"price":6.81,"value":3405.0,"ownership":{"direct":true},"balance_after":15042,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702710,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":600,"price":6.8,"value":4080.0,"ownership":{"direct":true},"balance_after":15542,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702709,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":600,"price":6.73,"value":4038.0,"ownership":{"direct":true},"balance_after":16142,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702708,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":300,"price":6.72,"value":2016.0,"ownership":{"direct":true},"balance_after":16742,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702707,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":100,"price":6.71,"value":671.0,"ownership":{"direct":true},"balance_after":17042,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702706,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":800,"price":6.7,"value":5360.0,"ownership":{"direct":true},"balance_after":17142,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702705,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":200,"price":6.67,"value":1334.0,"ownership":{"direct":true},"balance_after":17942,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702704,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:56:20.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":600,"price":6.64,"value":3984.0,"ownership":{"direct":true},"balance_after":18142,"source":{"system":"sec-edgar","filing":"0001251769-21-000070","document":"wf-form4a_162154776285607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000070/wf-form4a_162154776285607.xml","form_type":"4/A","original_submission_date":"2021-05-20"}},{"id":2702703,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":790,"price":6.96,"value":5498.4,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702702,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":600,"price":6.93,"value":4158.0,"ownership":{"direct":true},"balance_after":790,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702701,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":3400,"price":6.92,"value":23528.0,"ownership":{"direct":true},"balance_after":1390,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702700,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":5524,"price":6.91,"value":38170.84,"ownership":{"direct":true},"balance_after":4790,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702699,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":3144,"price":6.9,"value":21693.6,"ownership":{"direct":true},"balance_after":10314,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702698,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":464,"price":6.89,"value":3196.96,"ownership":{"direct":true},"balance_after":13458,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702697,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":1100,"price":6.88,"value":7568.0,"ownership":{"direct":true},"balance_after":13922,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702696,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":20,"price":6.85,"value":137.0,"ownership":{"direct":true},"balance_after":15022,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702695,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":500,"price":6.81,"value":3405.0,"ownership":{"direct":true},"balance_after":15042,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702694,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":600,"price":6.8,"value":4080.0,"ownership":{"direct":true},"balance_after":15542,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702693,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":600,"price":6.73,"value":4038.0,"ownership":{"direct":true},"balance_after":16142,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702692,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":300,"price":6.72,"value":2016.0,"ownership":{"direct":true},"balance_after":16742,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702691,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":100,"price":6.71,"value":671.0,"ownership":{"direct":true},"balance_after":17042,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702690,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":800,"price":6.7,"value":5360.0,"ownership":{"direct":true},"balance_after":17142,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702689,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":200,"price":6.67,"value":1334.0,"ownership":{"direct":true},"balance_after":17942,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":2702688,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T17:50:01.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":600,"price":6.64,"value":3984.0,"ownership":{"direct":true},"balance_after":18142,"source":{"system":"sec-edgar","filing":"0001251769-21-000068","document":"wf-form4_162154738122636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176921000068/wf-form4_162154738122636.xml","form_type":"4"}},{"id":3154120,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-11T17:32:57.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":27749,"price":2.08,"value":57717.92,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"The shares underlying the option shall vest fully on the one year anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option shall vest fully on the one year anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan."}],"balance_after":59439,"derivative":{"exercise_price":2.08,"expiration_date":"2030-05-07","underlying":"Common Stock","underlying_shares":27749},"source":{"system":"sec-edgar","filing":"0001251769-20-000055","document":"wf-form4_158923276040346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176920000055/wf-form4_158923276040346.xml","form_type":"4"}},{"id":3154119,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-11T17:32:57.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":10006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the grant of Restricted Stock Units (\"RSU\"). Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock pursuant to the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan. The RSUs vest fully on the one year anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Incentive Plan."}],"balance_after":18742,"source":{"system":"sec-edgar","filing":"0001251769-20-000055","document":"wf-form4_158923276040346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176920000055/wf-form4_158923276040346.xml","form_type":"4"}},{"id":3432932,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-08-20T16:33:49.000Z","date":"2019-08-16","kind":"grant","acquired":true,"shares":0,"price":3.27,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Fully vested at one year anniversary of grant date."}],"balance_after":31690,"derivative":{"exercise_price":3.27,"exercise_date":"2020-08-16","expiration_date":"2029-08-16","underlying":"Common Stock","underlying_shares":16536},"source":{"system":"sec-edgar","filing":"0001251769-19-000080","document":"wf-form4_156633321405738.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176919000080/wf-form4_156633321405738.xml","form_type":"4"}},{"id":3432931,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-20T16:33:49.000Z","date":"2019-08-16","kind":"grant","acquired":true,"shares":5399,"price":3.27,"value":17654.73,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Fully vested at one year anniversary of grant date."}],"balance_after":8736,"source":{"system":"sec-edgar","filing":"0001251769-19-000080","document":"wf-form4_156633321405738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176919000080/wf-form4_156633321405738.xml","form_type":"4"}},{"id":4133056,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-13T17:27:46.000Z","date":"2017-12-12","kind":"grant","acquired":true,"shares":15154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award is issued pursuant to the 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/12th of the shares subject to the option will vest on each one-month anniversary of December 12, 2017."}],"balance_after":15154,"derivative":{"exercise_price":3.98,"expiration_date":"2027-12-12","underlying":"Common Sock","underlying_shares":15154},"source":{"system":"sec-edgar","filing":"0001251769-17-000085","document":"wf-form4_151320405275293.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176917000085/wf-form4_151320405275293.xml","form_type":"4"}},{"id":4133055,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":23370,"kind":"person","name":"Pacitti David","position":1,"cik":"0001722733","reported_name":"Pacitti David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Sock","published_at":"2017-12-13T17:27:46.000Z","date":"2017-12-12","kind":"grant","acquired":true,"shares":3337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award is issued pursuant to the 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"1/12th of the shares will vest on each one-month anniversary of December 12, 2017."}],"balance_after":3337,"source":{"system":"sec-edgar","filing":"0001251769-17-000085","document":"wf-form4_151320405275293.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000125176917000085/wf-form4_151320405275293.xml","form_type":"4"}}]}